IBEX Q4 2026 Earnings Call Transcript

Quartr
Provided by Quartr
September 10, 2026

Key Takeaways

  • Positive Sentiment: Record fiscal 2026 performance included revenue of $644.1 million, up 15.4%, record adjusted EBITDA of $82.4 million, and record free cash flow of $31.2 million.
  • Positive Sentiment: IBEX added nine trophy clients in the fourth quarter and 17 for the year, while client retention exceeded 99% and client NPS remained strong at 71.
  • Positive Sentiment: AI-enabled solutions are gaining traction across five verticals, with deployments achieving resolution rates above 20%-40% and customer satisfaction above 4.7 out of 5; management said AI is generating incremental rather than cannibalized revenue.
  • Positive Sentiment: Health tech revenue grew 38% for the year to $114 million, surpassing the company’s $100 million target, and management highlighted strong pipelines in health care, e-commerce, and travel.
  • Negative Sentiment: Fourth-quarter adjusted EBITDA margin declined to 12.3% from 13.9% a year earlier due to new-client training costs, nearshore-to-offshore transitions, and higher fuel-related expenses, although management expects margin expansion in the first quarter of fiscal 2027.
AI Generated. May Contain Errors.
Earnings Conference Call
IBEX Q4 2026
00:00 / 00:00

Transcript Sections

Skip to Participants
Operator

Hello, and welcome to IBEX fourth quarter, full year 2026 earnings conference call. At this time, all participants are on a listen-only mode. After the speaker's presentation, there will be a question-and-answer session. To ask the question during the session, you will need to press star one one on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star one one again. To note, there is an accompanying presentation available on the IBEX Investor Relations website at investor.ibex.co. I would now like to hand the conference over to Mr. Greg Bradbury, Investor Relations for IBEX. Sir, you may begin.

Greg Bradbury
Senior Associate at Gateway Group

Good afternoon, and thank you for joining us today. Before we begin, I want to remind you that matters discussed on today's call may include forward-looking statements related to our operating performance, financial goals, and business outlook, which are based on management's current beliefs and assumptions. Please note that these forward-looking statements reflect our opinion as of the date of this call, and we undertake no obligation to revise this information as a result of new developments, which may occur. Forward-looking statements are subject to various risks, uncertainties, and other factors that could cause our actual results to differ materially from those expected and described today. For a more detailed description of our risk factors, please review our annual report on Form 10-K, filed with the U.S. Securities and Exchange Commission on September 10th, 2026, and any other risk factors we include in the subsequent filings with the SEC.

Greg Bradbury
Senior Associate at Gateway Group

With that, I will now turn the call over to IBEX CEO, Bob Dechant.

Bob Dechant
Bob Dechant
CEO at IBEX

Thanks, Greg. Good afternoon, and thank you all for joining us today as we review our fourth quarter and fiscal year 2026 results. I am pleased to report that our fourth quarter marked another period of outperformance, continuing the momentum we have built throughout fiscal 2026 as we further expanded our differentiation while creating additional separation between IBEX and the rest of the traditional BPO market. We delivered record fourth quarter revenue, growing 12% to $164.3 million, bringing our full-year organic revenue growth to 15%, or $644.1 million. We also did this while generating full-year records for Adjusted EBITDA, EPS, adjusted EPS, operating cash flow, and free cash flow. The quarter also marked our sixth straight quarter of double-digit revenue growth. These results demonstrate the strength of IBEX and the separation we have from the competition. We have created a powerful flywheel that enables us to consistently outperform the market.

Bob Dechant
Bob Dechant
CEO at IBEX

It starts with our differentiation and proven track record, which enables us to win trophy new logo clients across key verticals. We then operationally outperform our competition, allowing us to rapidly take significant market share. As a result, we have built a business with best-in-class client retention rates. The proof points of our flywheel are clear. in Q4, our new logo engine accelerated considerably. During the period, we added nine new trophy logos, bringing our annual total to 17 wins across multiple verticals and geographies. For the year, revenue from our top five, top 10, and top 25 clients grew 24%, 22%, and 15%, respectively. This growth represents market share we are taking from our competitors.

Bob Dechant
Bob Dechant
CEO at IBEX

I am proud to report that IBEX was named Partner of the Year by three different Fortune 500 companies, all of which are top 10 clients, highlighting that our clients clearly recognize the impact of our solutions on their business outcomes. In fiscal 2026, we recorded revenue and client retention rates north of 99%, indicating our ability to deliver not just for a select few clients, but across our client base. Additionally, our client NPS remains world-class at 71. While our financial results already underscore this point, it is another strong validation that our clients remain incredibly supportive of the work we are doing. On the topic of growth, earlier this year, we announced our target of growing the health tech vertical into a $100 million business by the end of the fiscal year.

Bob Dechant
Bob Dechant
CEO at IBEX

During the fourth quarter, the segment grew 42% to $29.4 million and grew 38% for the full year to $114 million, significantly surpassing the revenue goal we set for the business. What makes that performance especially compelling is that this growth has been built organically and will continue to be one of IBEX's most important growth vectors in fiscal 2027 and beyond. While health tech represents a large and important vertical to us, it also serves as a strong showcase of our proven ability to build and scale new verticals organically across new geographies, further validating our ongoing investment and expansion into additional high-growth markets. One attribute of IBEX that I am particularly proud of is our ability to improve as we grow. That applies to our business, our team, and our brand.

Bob Dechant
Bob Dechant
CEO at IBEX

I am pleased to report that our employee NPS increased this year from an already impressive 77 to 82, with a 95% participation rate, putting us in unprecedented territory, not only amongst traditional BPO peers, but across all industries. This is an important part of our competitive moat and a foundation for our ability to consistently outperform the competition. Fiscal 2026 also marked a transformational step forward in defining a new era of BPO, one powered by AI agents. Our strategic partnership with Sierra AI firmly establishes IBEX as a leading provider of AI agents. We bring an integrated solution to market that enables us to deliver both effective AI agent call containment and high levels of customer satisfaction. Many studies, including one by MIT, have highlighted that AI agent solutions often fall short on ROI or deliver poor-quality interactions.

Bob Dechant
Bob Dechant
CEO at IBEX

Our solution is designed to deliver both significant cost savings and high-quality AI-driven interactions. It combines a best-in-class AI agent engine with our best-in-class business insights to create customer journeys that deliver the and. We formalized the strategic partnership in late January and announced it publicly in May. In that short period of time, we have achieved tremendous traction across both new and existing clients, demonstrating that our AI strategy is translating into a transformational success for our clients and IBEX. The following are four distinct and meaningful case studies that highlight the progress we are making at AI speed. In the first, IBEX beat out a pure-play AI technology company, a SaaS technology company, and a traditional multibillion-dollar BPO peer to win and launch an AI agent partnership with Philippine Airlines, an existing IBEX client.

Bob Dechant
Bob Dechant
CEO at IBEX

We won the proof of concept in Q4 and reached full-scale deployment at the start of fiscal 2027. During the proof of concept phase, IBEX launched an AI agent solution in three languages, English, Tagalog, and Taglish, achieved resolution rates above 20%, and delivered CSAT above 4.7 out of 5.0, on par with our traditional human agents while our competitors struggled. Importantly, and consistent with our thesis going in, this solution is not cannibalizing our revenues. As we continue to be a critical partner, we are able to take share from our BPO competitors on the human agent side. This is a significant net win and a strong early proof point of how we intend to win in the evolving BPO 3.0 market. The second example is with BJ's Wholesale, a new trophy client win in which we led with our AI solution, not traditional BPO.

Bob Dechant
Bob Dechant
CEO at IBEX

We launched in June and achieved impressive results in weeks, not months. We are attaining resolution rates above 40% and CSAT scores above 4.7 out of 5.0, exceeding the human agent scores delivered by the client's legacy BPO vendor. Based on the outstanding performance and the strength of the partnership we have forged, we now anticipate launching traditional human agents in the first half of fiscal 2027. This adds another dimension to our powerful land and expand model. We believe BJ's is a great illustration of our ability to lead with AI, deliver meaningful client outcomes, and then win additional business, proving that our AI agent solutions are not merely an ancillary offering, but a leading solution that will drive future growth. The third example comes from deploying Sierra AI on our digital customer acquisition business.

Bob Dechant
Bob Dechant
CEO at IBEX

In this case, we are leveraging AI agent solutions we built to take inbound call volume that were previously handled through a traditional IVR and converting them into incremental sales opportunities for our human agents. This creates a virtuous cycle. We are easily able to scale to answer all the call volume generated through our own digital marketing efforts, efficiently convert them into additional revenue opportunities, and reinvest in new digital marketing campaigns to further expand this growing business. The last and fourth example highlights the strength of our partnership. Not only are we winning new business by leading with the IBEX Sierra solution, but we are also winning traditional CX business through the partnership. Earlier in the year, Sierra introduced us to a leading luxury activewear brand seeking the right partner to scale human agent support alongside its AI solution as the brand experiences hypergrowth.

Bob Dechant
Bob Dechant
CEO at IBEX

Based on the strength of Sierra AI's partnership and the trust it had developed with the client, we signed and launched a proof of concept within 30 days. Following our outperformance versus the incumbent vendor, we signed a long-term agreement and are now executing an aggressive ramp. This is a great example of how our traditional BPO can work and now move at the speed of AI, not BPO. Each of these four solutions are driving incremental growth for IBEX, and we currently have double-digit client deployments with our AI agent solution spread across five verticals, creating additional vectors of growth. Importantly, we have now turned the perceived threat of AI for BPOs into an important growth opportunity for IBEX. The result is a business that is strategically built for today and tomorrow.

Bob Dechant
Bob Dechant
CEO at IBEX

For many quarters, we have demonstrated our ability to outperform the traditional BPO market on the human agent side of the business. Now we have created the ability to deliver best-in-class AI agents as well, which gives us confidence in our ability to continue to deliver on our growth trajectory, both near-term and long-term. To summarize, we will look back on fiscal 2026, not only as another banner year across the business, but also as the start of something greater. We began to define the new era of BPO 3.0, and we are confident in our ability to build on this momentum and solidify IBEX's industry leadership position. I firmly believe our business today is stronger than ever and that we are best positioned for the future. Lastly, I want to thank my team for their tireless efforts in making IBEX the best in the industry.

Bob Dechant
Bob Dechant
CEO at IBEX

With that, I will now turn the call over to Taylor to go into more detail on our fourth quarter and fiscal year 2026 financial results and guidance. Taylor?

Taylor Greenwald
Taylor Greenwald
CFO at IBEX

Thank you, Bob, and good afternoon, everyone. Thank you for joining the call today. In my discussions of our fourth quarter and fiscal year 2026 financial results, references to revenue, net income, and net cash generated from operations are on a U.S. GAAP basis, while adjusted net income, adjusted earnings per share, Adjusted EBITDA, and free cash flow are on a non-GAAP basis. Reconciliations of our U.S. GAAP to non-GAAP measures are included in the tables attached to our earnings press release. Turning to our results, we had a strong fourth quarter across many key operating metrics, including revenue, Adjusted EBITDA, EPS, and free cash flow. This was our sixth consecutive quarter of double-digit revenue growth, resulting in top-line growth of 12% for the quarter. Our differentiated solutions and execution are clearly separating us from the traditional BPO pack.

Taylor Greenwald
Taylor Greenwald
CFO at IBEX

Fourth quarter revenue was $164.3 million, up from $147.1 million in the prior year quarter. Revenue growth was driven by vertical growth in health tech of 42%, technology of 27%, travel, transportation, and logistics of 18%, retail and e-commerce of 7%, with help from growth in our AI agent solutions. We continued to win and grow in all geographic markets during the quarter. Our onshore region grew 15% compared to the prior year quarter, driven by clients won and launched during fiscal year 2026, including several clients in our higher-margin health tech vertical. Our highest margin offshore region grew 14% from the prior year quarter, and our nearshore locations grew 2%. Offshore revenue comprised 50% of total revenue, allowing us to maintain our strong gross margin of 28.6% for the quarter. Onshore revenue expanded to 28% of total revenue from 27% in the prior year quarter.

Taylor Greenwald
Taylor Greenwald
CFO at IBEX

Our higher margin digital and omnichannel services also continue to strengthen, growing 12% versus the prior year quarter to 82% of total revenue. This continued mix shift reflects the growing contribution of our digital and AI-enabled solutions and reinforces the strategic and financial impact as deployments begin to scale. We have structurally built IBEX so that our growth vectors are our highest margins regions, services, and vertical markets, and we expect that we will continue to be successful driving long-term margin growth. Fourth quarter GAAP net income was $8.7 million, compared to $9.6 million in the prior year quarter. Results were primarily driven by training expenses related to the many new client wins in the quarter and temporary impact of work transferring from nearshore to offshore delivery centers, as well as the impact of higher fuel prices on utility and transportation expenses, particularly in our offshore region.

Taylor Greenwald
Taylor Greenwald
CFO at IBEX

Our GAAP results also include $2 million of lease termination losses and severance expenses associated with the shift of work from our nearshore to offshore regions, as well as impairment losses and asset disposal gains. Our tax rate was 10% versus 19% in the prior year quarter, primarily attributable to changes in revenue mix across our taxable jurisdictions and discrete tax items, including a favorable resolution of an uncertain tax position during the current year. Fully diluted GAAP EPS was $0.59, down from $0.66 in the prior quarter. Moving to non-GAAP measures, Adjusted EBITDA decreased slightly to $20.2 million, or 12.3% of revenue, from $20.5 million, or 13.9% of revenue for the same period last year, and driven primarily by the expenses related to new client wins, the temporary impact of work transferring from nearshore to offshore, as well as the impact of higher fuel prices.

Taylor Greenwald
Taylor Greenwald
CFO at IBEX

We expect Adjusted EBITDA margins to return to expanding in the first quarter of fiscal year 2027. In addition to our customary non-GAAP adjustments of stock-based compensation and foreign currency gains and losses, our non-GAAP results also exclude the $2 million of lease termination losses, severance expense, impairment losses, and asset disposal gains discussed above. Adjusted net income remained consistent at $12.7 million when compared to the prior quarter. Non-GAAP fully diluted adjusted earnings per share was $0.85 compared to $0.87 in the prior quarter. As a company, we're pleased with the client diversification we've established over the last several years.

Taylor Greenwald
Taylor Greenwald
CFO at IBEX

For the fourth quarter of fiscal year 2026, our largest client accounted for 9% of revenue, and our top five, top 10, and top 25 clients represented 33%, 53%, and 75%, respectively, of overall revenue, compared to 36%, 54%, and 79%, respectively, of overall revenue in the prior quarter, representative of a well-diversified client portfolio, which continues to diversify with new clients. Over the past decade, we have done a tremendous job of not only retaining our top 25 clients, but also winning and growing new strategic clients. Two great examples of this are two of our signature client wins from fiscal year 2025 going into top 25 clients, and one of our signature client wins from fiscal year 2024, growing into a top 10 client. Switching to our verticals, health tech grew 42% and increased to 17.9% of fourth quarter revenue versus 14% in the prior quarter.

Taylor Greenwald
Taylor Greenwald
CFO at IBEX

Technology grew 27% and increased to 8.4% compared to 7.4%. Travel, transportation, and logistics grew 18% and increased to 14.5% compared to 13.8%. Retail and e-commerce grew 7% and comprised 24.2% of total revenue compared to 25.3% in the prior quarter. These increases were driven by continued growth in multiple offshore geographies and our continued ability to win significant new clients in these verticals. Conversely, our exposure to the lower margin telecommunications vertical decreased to 9.4% of revenue for the quarter versus 10.9% in the prior quarter, as we see lower volume from legacy carriers. Revenues from the fintech vertical were up 3% and represented 9.7% of revenue for the quarter versus 10.6% in the prior quarter. Moving on to our full-year results, we achieved record full-year revenue, Adjusted EBITDA, EPS, adjusted EPS, operating cash flow, and free cash flow for fiscal year 2026.

Taylor Greenwald
Taylor Greenwald
CFO at IBEX

Fiscal year 2026 revenue was $644.1 million, an increase of 15.4% from $558.3 million in the prior year. Revenue growth was driven by vertical growth in health tech of 38%, technology of 26%, travel, transportation, and logistics of 17%, and retail and e-commerce of 14%, along with accelerating growth in our digital acquisition business and our AI agent solutions. During fiscal year 2026, these AI-enabled offerings progressed from an emerging growth vector to becoming a more meaningful contributor to our results, supporting both new client wins and expansion within our embedded base. We grew in both our onshore and offshore regions throughout the year. Our onshore region grew 25% compared to the prior year, driven by growth of several clients in our higher margin health tech vertical and our high-margin AI agent solutions and digital acquisition business.

Taylor Greenwald
Taylor Greenwald
CFO at IBEX

Our highest margin offshore region comprised 51% of total revenue and grew 16% compared to the prior year. Revenue from our nearshore locations grew 5% compared to the prior year. Fiscal year 2026 net income increased to $46.3 million versus $36.9 million in the prior year. The increase was primarily driven by the continued revenue growth and operating leverage gained from SG&A expenses. Our effective tax rate was 14.7% versus 19.7% for fiscal year 2026, which was attributable to changes in revenue mix across our taxable jurisdictions and discrete items recognized in the current year. Excluding the discrete tax benefits from stock-based compensation and favorable resolution of uncertain tax positions, our effective tax rate would have been 18.2% for fiscal year 2026. We expect our normalized tax rate going forward to be in a 20%-22% range.

Taylor Greenwald
Taylor Greenwald
CFO at IBEX

Benefiting from higher net income and lower diluted shares outstanding, our GAAP fully diluted earnings per share increased 32.8% to $3.13. Reviewing our non-GAAP measures for the full year, Adjusted EBITDA increased to a record of $82.4 million compared to $72 million for the prior year. Adjusted EBITDA margin was 12.8% for fiscal year 2026, consistent with 12.9% for the prior year. Adjusted net income increased 21% to $52.2 million, compared to $43 million in the prior year. Non-GAAP fully diluted adjusted earnings per share increased 28% to $3.52 compared to $2.75. The increase in non-GAAP adjusted net income and non-GAAP fully diluted earnings per share was primarily driven by the top and bottom line operating performance discussed earlier and our lower tax rate and share count.

Taylor Greenwald
Taylor Greenwald
CFO at IBEX

Moving to cash flow, net cash generated from operating activities was a record $59 million for fiscal year 2026 compared to $45.7 million for fiscal year 2025, which was driven by an increase in our revenues and profitability, offset by higher use of working capital. Our DSOs were 69 days for the quarter, down from 72 days at the end of last year. We expect our DSOs to remain stable in the low to mid-70s on a go-forward basis. Capital expenditures were $27.8 million or 4.3% of revenue for fiscal year 2026, versus $18.4 million or 3.3% of revenue in the prior year. This increase was primarily driven by expansions in our offshore regions and purchases of IT and telecommunications equipment to support the company's continued growth.

Taylor Greenwald
Taylor Greenwald
CFO at IBEX

Free cash flow for fiscal year 2026 was a record inflow of $31.2 million, compared to an inflow of $27.3 million in the prior year. The increase was primarily driven by the increase in net cash generated from operating activities, offset by the planned increase in capital expenditures. We are proud to have achieved record cash flow levels while investing for high growth. During the quarter, we repurchased 143,000 shares for $4.3 million at an average price of $29.83, bringing our fiscal year share repurchases to 453,000 shares for $14.4 million at an average price of $31.70. On May 11th, 2026, the board authorized a new share repurchase program for $20 million, and the total amount available for repurchase as of June 30th, 2026, was $17.9 million.

Taylor Greenwald
Taylor Greenwald
CFO at IBEX

We ended the fourth quarter with $32.6 million of cash and debt of $1.7 million for a net cash position of $30.9 million, an improvement of $16.9 million compared to net cash of $14 million at the end of the third quarter, an improvement of $17.2 million compared to net cash of $13.7 million at the end of our last fiscal year. I am also pleased to mention two additional items. First, we just renewed our revolving HSBC credit facilities through October 2029 with a total capacity of up to $76 million. Additionally, as it has now been over five years since our IPO, we have exited emerging growth status and are well prepared for the SOX certification process to attest to the effectiveness of our financial reporting and disclosure controls.

Taylor Greenwald
Taylor Greenwald
CFO at IBEX

Looking back, fiscal 2026 was a banner year that included record performance across many key operating metrics, including revenue, Adjusted EBITDA, EPS, and free cash flow. Our financial results were driven by consistent performance throughout the year, supported by our differentiated strategy and increased traction in our AI-enabled solution offerings. Looking ahead, this momentum gives us confidence that our strategy will continue generating results that outpace our market as we head to fiscal year 2027. Forecasting the year ahead, our healthy balance sheet and cash flows are enabling us to continue to make smart investments to support increased capacity for anticipated growth, as well as to further extend our current AI leadership position. Reflective of our current position and forward momentum, we are providing initial first quarter and fiscal year 2027 revenue and Adjusted EBITDA guidance.

Taylor Greenwald
Taylor Greenwald
CFO at IBEX

For fiscal year 2027, revenue is expected to be in the range of $700 million-$715 million, or 9%-11% growth. Adjusted EBITDA is expected to be in the range of $90 million-$94 million, or 9%-14% growth. For first quarter fiscal year 2027, revenue is expected to be in the range of $168 million-$170 million or 11%-12% growth. Adjusted EBITDA is expected to be in the range of $22 million-$23 million or 13%-18% growth. Capital expenditures for the year are expected to be in the range of $25 million-$30 million. Our business is well-positioned for today and the years ahead, and we're excited about the momentum we have built as we head into fiscal year 2027 and beyond. With that, Bob and I will now take questions. Operator, please open the line.

Operator

Thank you. Ladies and gentlemen, as a reminder to ask a question, please press star one one on your telephone, then wait for your name to be announced. To withdraw your question, please press star one one again. Please stand by while we compile the Q&A roster. Our first question comes from the line of Jacob Haggarty with Baird. Your line is open.

Jacob Haggarty
Jacob Haggarty
Analyst at Baird

Hey, guys. Congrats on another great quarter here. Just a question real quick. Your growth has accelerated pretty nicely since the AI fears have kicked in, ironically. Are you guys already seeing benefits from AI? Is that part of what's driving this growth, or can that be an accelerating factor in the years to come here?

Bob Dechant
Bob Dechant
CEO at IBEX

Hey, Jacob. It's Bob, and thanks for the question and appreciate your being on the call. Here's my belief is our performance continues to stand out, and that's noticed by potential clients that are looking at us, et cetera. When we do the announcement with Sierra AI, such a strong player in the AI world, it also helps them take notice, and it puts us, I think, into a different classification versus the rest of the pack, and really moves us into that position of being a BPO player that can be their partner for today in the human world, but also be their partner as they now evolve in the bringing AI agents to market. It further differentiates us, and I think that's what we're seeing is the acceleration of our business, our traditional business, our ability to win new logos.

Bob Dechant
Bob Dechant
CEO at IBEX

It also now creates what we're really excited about is another dimension for growth. Because if you think about our implementations. We go from a proof of concept to rapidly full deployment. We go to 20%-40% of their enterprise volume, as I highlighted in those case studies. Now, do you know how long that would take to hire to 20%-40% on the human side between training and hiring? It takes a long time to build that type of scale. Now we're building that scale almost immediately with the scale of the AI agent solution. So we think pathway to revenue for that is really exciting. So we just think that that adds a whole other dimension of growth to our business.

Bob Dechant
Bob Dechant
CEO at IBEX

Like I said, in the face of the threat of AI, and we are out in front of it, so we actually truly believe we future-proofed this business.

Jacob Haggarty
Jacob Haggarty
Analyst at Baird

Yeah. No, that makes a lot of sense. Just a modeling question really quick. On the FQ4 tax rate, it was a bit lower. How do you think about that for the coming year? Should that go back to near 20%, or does that stay structurally lower for a little bit?

Taylor Greenwald
Taylor Greenwald
CFO at IBEX

Good question, Jacob, and good to hear from you. You are right. Going forward, we expect our tax rate to continue to be in that 20%-22% range. The fourth quarter, we benefited from some discrete tax items, including a favorable resolution from a tax matter with the tax authority. I think for modeling purposes, 20%-22% would be the right range.

Jacob Haggarty
Jacob Haggarty
Analyst at Baird

Awesome. Thank you, guys.

Operator

Thank you. Please stand by for our next question. Our next question comes from the line of David Paige with RBC. Your line is open.

David Paige
David Paige
Analyst at RBC

Hi, good afternoon. Thank you for taking my question. Congrats on the good results. Looks like a broad-based growth across all four verticals. I was just wondering if you could provide a little bit more color on each vertical out into 1Q and to 2027. Is growth going to be accelerating or where should we be focused on? Thanks so much.

Bob Dechant
Bob Dechant
CEO at IBEX

Sure, David. Thank you for joining. Thank you for that question. I like how you touched on that because we are seeing growth in our key verticals, and that is something that we believe is important, how we have built ourselves as a diversified business from a client and a vertical standpoint. Let us start with the healthcare health tech vertical. We are doing an amazing job with the big payers, and the pipeline is really strong in that space with those players. We feel like that will continue to fuel a lot of growth for us as we win those throughout the course of this year. Our pipeline is really strong there. We have also won in what I will call more specialty areas of the healthcare ecosystem, things like non-emergency medical transportation, where we are just winning deal after deal after deal.

Bob Dechant
Bob Dechant
CEO at IBEX

We are really excited because we have the strength of those that have massive budgets for CX, and then we are winning with the specialty companies that allow us to really have a really strong one-two punch. When I think about the e-commerce world, we are doing very well in the e-commerce world. We are winning new logos. We are winning as the e-commerce world is looking for disruptive markets, low price points. Our Pakistan market is on fire, growing rapidly, as are several of our other low-cost markets. One area of growth there is we are just winning massive market share against our competitors by simply outperforming them, which is a really good position to be in because that is obviously then really sticky if you are outperforming, if you are growing with them. Then if you are bringing some of these innovative solutions, you become a more and more trusted partner.

Bob Dechant
Bob Dechant
CEO at IBEX

I think we are doing very well in that space. I would say similarly in the travel transportation, where we are winning. Look, we highlighted what we did with Philippine Airlines. We are deferring and containing a lot of what calls that we are going to humans with AI, but we are doing that, we are winning market share, and we are growing with them. We are able to win new businesses just based on what we are doing and as a business, our differentiated value proposition. As I look into 2027, I feel really strong about the trajectory of the business. The nine new logos I do not think are a one-off that we did in Q4.

Bob Dechant
Bob Dechant
CEO at IBEX

I really think that is a combination of the brand that we have created, the differentiation that we continually highlight, and then our strong AI play, and in particular, AI agent play, where our competition in the BPO space, they are not leaning into this. We are well ahead of anybody in the pack. As clients look at that, they want a provider that can deliver successful AI agents. That is the solution that we built with Sierra AI, leveraging the strength of them and the strength of us, and we put it together. As you can see, we are delivering the and. That is resonating and that is driving growth. I feel really strong about the trajectory of this business.

David Paige
David Paige
Analyst at RBC

Great. That's very helpful. Thank you. Congrats on the good results.

Bob Dechant
Bob Dechant
CEO at IBEX

Great. Thank you. We're really proud of what we've done.

Operator

Thank you. Ladies and gentlemen, I'm showing no further questions in the queue. I would now like to turn the call back over to CEO Bob Dechant for closing remarks.

Bob Dechant
Bob Dechant
CEO at IBEX

Thanks, operator, and thanks all for participating today. As you can tell, we're really proud of the work that we've done here. It's all driven by the best team in the industry. I just want to thank them. A special call out to them. I appreciate all your efforts that you put out throughout the entire year. I couldn't be more proud of what you've done and what we've done as a company. Thank you all for joining us today, and we look forward to speaking with you shortly next quarter in November. Have a good night.

Operator

Ladies and gentlemen, that concludes today's conference call. Thank you for your participation. You may now disconnect.

Executives
Analysts
    • Greg Bradbury
      Senior Associate at Gateway Group
    • Jacob Haggarty
      Analyst at Baird
    • David Paige
      Analyst at RBC
Powered by Quartr